306 related articles for article (PubMed ID: 26076798)
21. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
22. Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma.
Verdonck LF; van Putten WL; Hagenbeek A; Schouten HC; Sonneveld P; van Imhoff GW; Kluin-Nelemans HC; Raemaekers JM; van Oers RH; Haak HL
N Engl J Med; 1995 Apr; 332(16):1045-51. PubMed ID: 7898521
[TBL] [Abstract][Full Text] [Related]
23. Novel therapies and role of transplant in the treatment of peripheral T-cell lymphomas.
Horwitz SM
Hematology Am Soc Hematol Educ Program; 2008; ():289-96. PubMed ID: 19074098
[TBL] [Abstract][Full Text] [Related]
24. How I treat the peripheral T-cell lymphomas.
Moskowitz AJ; Lunning MA; Horwitz SM
Blood; 2014 Apr; 123(17):2636-44. PubMed ID: 24615779
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.
Kitahara H; Maruyama D; Maeshima AM; Makita S; Miyamoto KI; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Tajima K; Terauchi T; Kurihara H; Taniguchi H; Komatsu N; Tobinai K
Ann Hematol; 2017 Mar; 96(3):411-420. PubMed ID: 27928587
[TBL] [Abstract][Full Text] [Related]
26. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
Perrone G; Farina L; Corradini P
Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
[TBL] [Abstract][Full Text] [Related]
27. The role of high-dose therapy in peripheral T-cell lymphomas.
Reimer P; Rüdiger T; Wilhelm M
Clin Lymphoma Myeloma; 2006 Mar; 6(5):373-9. PubMed ID: 16640812
[TBL] [Abstract][Full Text] [Related]
28. Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Gisselbrecht C; Lepage E; Molina T; Quesnel B; Fillet G; Lederlin P; Coiffier B; Tilly H; Gabarre J; Guilmin F; Hermine O; Reyes F;
J Clin Oncol; 2002 May; 20(10):2472-9. PubMed ID: 12011124
[TBL] [Abstract][Full Text] [Related]
29. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.
Blystad AK; Enblad G; Kvaløy S; Berglund A; Delabie J; Holte H; Carlson K; Kvalheim G; Bengtsson M; Hagberg H
Bone Marrow Transplant; 2001 Apr; 27(7):711-6. PubMed ID: 11360110
[TBL] [Abstract][Full Text] [Related]
30. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.
Armitage JO
Am J Hematol; 2012 May; 87(5):511-9. PubMed ID: 22508369
[TBL] [Abstract][Full Text] [Related]
31. Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.
Lefrère F; Delmer A; Suzan F; Levy V; Belanger C; Djabarri M; Arnulf B; Damaj G; Maillard N; Ribrag V; Janvier M; Sebban C; Casasnovas RO; Bouabdallah R; Dreyfus F; Verkarre V; Delabesse E; Valensi F; McIntyre E; Brousse N; Varet B; Hermine O
Leukemia; 2002 Apr; 16(4):587-93. PubMed ID: 11960337
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial.
Kim SJ; Yoon DH; Kang HJ; Kim JS; Park SK; Kim HJ; Lee J; Ryoo BY; Ko YH; Huh J; Yang WI; Kim HK; Min SK; Lee SS; Do IG; Suh C; Kim WS;
Eur J Cancer; 2012 Nov; 48(17):3223-31. PubMed ID: 22770877
[TBL] [Abstract][Full Text] [Related]
33. Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.
Czyz A; Romejko-Jarosinska J; Helbig G; Knopinska-Posluszny W; Poplawska L; Piatkowska-Jakubas B; Hawrylecka D; Nasilowska-Adamska B; Dytfeld D; Lojko-Dankowska A; Kopinska A; Boguradzki P; Walewski J; Kyrcz-Krzemien S; Hellmann A; Komarnicki M
Ann Hematol; 2013 Jul; 92(7):925-33. PubMed ID: 23471671
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: complete response at transplant predicts survival.
Kim MK; Kim S; Lee SS; Sym SJ; Lee DH; Jang S; Park CJ; Chi HS; Huh J; Suh C
Ann Hematol; 2007 Jun; 86(6):435-42. PubMed ID: 17256144
[TBL] [Abstract][Full Text] [Related]
35. Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?
Casulo C; Horwitz S
Curr Oncol Rep; 2010 Nov; 12(6):374-82. PubMed ID: 20737300
[TBL] [Abstract][Full Text] [Related]
36. Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?
Lunning MA; Horwitz S
Curr Treat Options Oncol; 2013 Jun; 14(2):212-23. PubMed ID: 23568456
[TBL] [Abstract][Full Text] [Related]
37. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.
Wilhelm M; Smetak M; Reimer P; Geissinger E; Ruediger T; Metzner B; Schmitz N; Engert A; Schaefer-Eckart K; Birkmann J
Blood Cancer J; 2016 Jul; 6(7):e452. PubMed ID: 27471868
[TBL] [Abstract][Full Text] [Related]
38. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
[TBL] [Abstract][Full Text] [Related]
39. Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry.
Ellin F; Landström J; Jerkeman M; Relander T
Blood; 2014 Sep; 124(10):1570-7. PubMed ID: 25006130
[TBL] [Abstract][Full Text] [Related]
40. Peripheral T-cell lymphomas: analysis of histology, staging and response to treatment of 208 cases at a single institution.
Broussais-Guillaumot F; Coso D; Belmecheri N; Ivanov V; Schiano de Collela JM; Aurran-Schleinitz T; Stoppa AM; Chetaille B; Xerri L; Esterni B; Blaise D; Bouabdallah R
Leuk Lymphoma; 2013 Nov; 54(11):2392-8. PubMed ID: 23410100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]